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Abstract
The discovery of expression quantitative trait loci (‘‘eQTLs’’) can help to unravel genetic contributions to complex traits. We
identified genetic determinants of human liver gene expression variation using two independent collections of primary
tissue profiled with Agilent (n=206) and Illumina (n=60) expression arrays and Illumina SNP genotyping (550K), and we
also incorporated data from a published study (n=266). We found that ,30% of SNP-expression correlations in one study
failed to replicate in either of the others, even at thresholds yielding high reproducibility in simulations, and we quantified
numerous factors affecting reproducibility. Our data suggest that drug exposure, clinical descriptors, and unknown factors
associated with tissue ascertainment and analysis have substantial effects on gene expression and that controlling for
hidden confounding variables significantly increases replication rate. Furthermore, we found that reproducible eQTL SNPs
were heavily enriched near gene starts and ends, and subsequently resequenced the promoters and 39UTRs for 14 genes
and tested the identified haplotypes using luciferase assays. For three genes, significant haplotype-specific in vitro
functional differences correlated directly with expression levels, suggesting that many bona fide eQTLs result from
functional variants that can be mechanistically isolated in a high-throughput fashion. Finally, given our study design, we
were able to discover and validate hundreds of liver eQTLs. Many of these relate directly to complex traits for which liver-
specific analyses are likely to be relevant, and we identified dozens of potential connections with disease-associated loci.
These included previously characterized eQTL contributors to diabetes, drug response, and lipid levels, and they suggest
novel candidates such as a role for NOD2 expression in leprosy risk and C2orf43 in prostate cancer. In general, the work
presented here will be valuable for future efforts to precisely identify and functionally characterize genetic contributions to
a variety of complex traits.
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Genome-wide association studies have uncovered numerous
robust associations between common variants and complex traits,
but only a minority of these can be traced to protein-altering
polymorphisms [1]. It is likely that most of these associations result
from non-coding variants. One hypothesis is that such variants
modify cis-regulatory sequences and thereby change the expres-
sion levels of one or more target genes. Variance in gene
expression plays essential roles in numerous important processes
and is highly heritable in human populations [2].
Considering this, the discovery of genetic variants that have a
functional impact on gene expression is a potentially powerful
means to facilitate more accurate and robust identification of
associations between variants and disease. Such discoveries may
also provide mechanistic insight into otherwise anonymous
genotype-phenotype correlations that often span many correlated
variants across multiple genes. In large part due to this potential
there has been recent substantial interest in the identification of
expression quantitative trait loci (eQTLs) [3–10].
Regulation of gene expression in the liver is of particular interest
given its vital roles in maintaining homeostasis and health,
including synthesis of most essential serum proteins, the produc-
tion of bile and its carriers, and the regulation of nutrients. The
liver is also the predominant organ in xenobiotic metabolism, and
it has been estimated that 75% of the 200 most widely prescribed
drugs are eliminated from the body through liver metabolism [11].
Altered metabolism by genetic factors affects the systemic
availability and residence time of xenobiotics and hence their
toxic and pharmacologic effects [12].
While eQTL studies have made valuable contributions to
genetic research (e.g., [13]), there exist several practical limitations
to consider. First, most eQTL studies are conducted in
immortalized, lymphoblastoid cell lines (LCLs), which clearly
have utility for the interpretation of human disease associations,
particularly with immunity-related phenotypes [14,15]. However,
the use of such cell lines potentially introduces artifacts associated
with immortalization, subsequent passage, and growth conditions
prior to harvest [16]. Second, eQTLs may exhibit spatiotemporal
specificity [17,18], presumably driven by polymorphisms located
within tissue specific regulatory elements, and eQTL studies may
be maximally informative for any given trait when conducted in a
relevant, non-transformed cell type. Third, environmental factors
and other, mostly hidden, confounding variables are known to
significantly affect gene expression levels and measurements [19–
23]. Fourth, most eQTL studies fail to provide replication on an
independent set of samples with independent experimental
assessment (see [24–27,23] for exceptions).
We sought to address these limitations, and conducted two
independent eQTL studies and compared these results to a third,
published study. Genetic analyses were performed using Bayesian
regression [28,29] after controlling for age, sex, ancestry, and
unmeasured confounding variables [20]. Using the UC liver panel
as a ‘discovery’ cohort and the UW and Merck data as replication
panels, we found that ,30% of eQTLs identified at stringent
thresholds failed to replicate in either of the two replication studies.
We show that this is likely due to several factors, including SNPs in
probes, but the effects of unmeasured confounding variables were
particularly pronounced. We also found that reproducible eQTL
associations were enriched near proximal promoters and 39 UTRs.
Through targeted resequencing and luciferase experiments, we
identified 3 significant haplotype-specific in vitro functional effects
that directly support a liver eQTL. These data functionally
validate the enrichment for eQTLs near gene ends and suggest
that many eQTLs can be rapidly fine mapped to a causative
variant or haplotype. Finally, given our study design we identified
hundreds of genes with reproducible SNP-associated expression
levels, a subset of which provide strong mechanistic hypotheses for
published associations between SNPs and disease.
Results
Three independent sample collections
We analyzed two independent sets of primary liver tissues at the
University of Chicago (UC; n=206) and University of Washing-
ton (UW; n=60). We genotyped both sets of samples using
Illumina SNP arrays (quad-610 and 550 k for UC and UW,
respectively); to improve mapping power [30,28] and replication
ascertainment, additional genotypes were imputed using HAP-
MAP reference genotype panels (see Methods). Gene expression
levels were analyzed using Agilent (UC) and Illumina (UW)
expression arrays. We considered the UC liver collection as a
‘discovery’ set and used as replication panels the UW collection
and a published set of liver eQTL data (Merck; n=266) [31].
However, we note that the conclusions drawn below were robust
to the choice of a ‘discovery’ set (Figure S1). All samples analyzed
across all three studies were unique. Microarray expression probes
from both platforms were remapped to RefSeq gene models to aid
in cross platform comparisons. A total of 14,703 RefSeq genes
were surveyed in the UC reference study while 11,245 RefSeq
genes were present on all three platforms. We have made these
data and results publicly available through the GEO and SCAN
databases (http://www.scandb.org/) [32].
Demographic effects
After correcting for technical effects and unmeasured con-
founding variables, we found that thousands of gene expression
traits were significantly associated with demographic variables. At
a 5% false discovery rate (FDR), 769, 336, and 3,110 genes were
significantly associated with ancestry, sex, and age, respectively
Author Summary
Many disease-associated genetic variants do not alter
protein sequences and are difficult to precisely identify.
Discovery of expression quantitative trait loci (eQTL), or
correlations between genetic variants and gene expression
levels, offers one means of addressing this challenge.
However, eQTL studies in primary cells have several
shortcomings. In particular, their reproducibility is largely
unknown, the variables that generate unreliable associa-
tions are uncharacterized, and the resolution of their
findings is constrained by linkage disequilibrium. We
performed a three-way replication study of eQTLs in
primary human livers. We demonstrated that ,67% of cis-
eQTL associations are replicated in an independent study
and that known polymorphisms overlapping expression
probes, SNP-to-gene distance, and unmeasured confound-
ing variables all influence the replication rate. We fine-
mapped 14 eQTLs and identified causative polymorphisms
in the promoter or 39UTR for 3 genes, suggesting that a
considerable fraction of eQTLs are driven by proximal
variants that are amenable to functional isolation. Finally,
we found hundreds of overlaps between SNPs associated
with complex traits and replicated eQTL SNPs. Our data
provide both cautionary (i.e. non-reproducibility of many
strong eQTLs) and optimistic (i.e. precise identification of
functional non-coding variants) forecasts for future eQTL
analyses and the complex traits that they influence.
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(FDR,5%, Figure 1, Figure S2, examples displayed in Figure S3)
have a marked enrichment for small p-values in both replication
samples (Figure 1A, 1D). To lessen the influence of differential
statistical power among the three studies (n=206, 60, 266), we
defined ‘replication’ as having a nominally significant p-value in
the independent sample (p-value,0.05) and having a concordant
effect direction (i.e., is YFG more highly expressed in males or
females?). 29.9% and 32.1% of genes significantly affected by sex
(UC sex t-test FDR,5%) replicated in the UW and Merck studies,
respectively (Figure 1B). At more stringent thresholds, validation
rates exceeded 80%, albeit with fewer included genes (Figure 1B).
We also note that the sex-associated gene set was strongly enriched
for genes on the X and Y chromosomes (Figure 1C; X
chromosome, hypergeometric test, p-value=1.72610
214,Y
chromosome, p-value,2610
216), as would be expected for genes
with sex-associated expression levels. Effects due to age were less
reproducible: 13.2% and 21.5% of significantly age associated
genes (UC age t-test FDR,5%) replicated in the UW and Merck
studies, respectively (Figure 1E; an example of a replicated age-
associated gene, TMEM22, is displayed in Figure 1F). Effect sizes
for both sex and age were correlated across studies (Figure S4;
Spearman’s rho, UC-UW sex=0.597, UC-Merck sex=0.720,
UC-UW age=0.333, UC-Merck age=0.159), underscoring the
reproducibility of demographic effect estimates.
It is possible that both age and sex replication rates are
downwardly biased due to differences in age and sex distributions
(Table 1). To quantify the potential effects of heterogeneous
sample sizes and unbalanced study designs, we performed
resampling studies within the UC discovery cohort. Demographic
effect replication rates were recalculated using 60 samples that
were race, sex, and age (+/23years) matched to the UW
distribution (Figure 1B, 1E; see Methods). We found that 34%
of sex effects and 15% of age effects replicated by simulation,
supporting the conclusion that sample size and demographic
heterogeneity do generate significant covariate associations that
our replication studies are unable or underpowered to detect.
cis-eQTL mapping
After adjusting for age, sex, ancestry, and unmeasured con-
founding variables (quantified by surrogate variable analyses, see
Methods and [20]),we found 1,787 gene models with significant cis-
linked genetic effects on expression levels (UC log10 Bayes Factor
(BF).5; SNP to TSS distance ,250 kb; Figure 2A, Figure 3A,
Table S1). The distribution of t-test p-values in the replication sets,
adjusted for the same covariates, for the UC best associated gene-
Figure 1. Age and sex effect replication. (A,D) Replication panel linear regression t-test p-values for genes with significant Sex (A) and Age (D)
effects in the UC panel (,5% FDR) were binned (x-axis) and the number of genes per bin (y-axis) is displayed separately for the UW (red) and Merck
(blue) replication sets. (B,E) The replication rate of sex (B) and age (E) associations is depicted as a function of UC p-value for UW (red), Merck (blue),
either replication study (green), and for the n=60 resampled data (purple). Note that, at more stringent significance thresholds, the replication rate
increases but fewer genes are included. (C) Genes with significant sex associations are enriched on the X (black) and Y (grey) chromosomes.
Hypergeometric test p-values (y-axis, log10 scaled) are plotted as a function of the discovery set effect significance threshold (x-axis, log10-scaled). (F)
An example of a gene (TMEM22) whose expression level (y-axis) is associated with age (x-axis). Each point represents the expression level (y-axis),
adjusted for surrogate variables, and age (x-axis) of an individual sample.
doi:10.1371/journal.pgen.1002078.g001
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indicating that a large fraction of cis-eQTLs are reproducible in
independent sample collections. As with demographic effects, we
defined replication as a p-value,0.05 and a concordant allele effect
direction (Figure 3C). While the significance of association in the
discovery cohort has a large effect on replication probability, the
relationship between significance and replication was effectively
binary (Figure 3C). Cis-eQTLs with BFs.5 were much more likely
to replicate than those with BFs,5 (chi square p-value,2610
216).
However, among genes with BFs.5, replication probability was
only weakly dependent upon BF (Figure 3C; logistic regression chi-
squared p-value=0.00319).
We found that 49.1% and 57.6% of significant cis-eQTLs (UC
BF.5) replicated in the UW and Merck studies, respectively (i.e.,
p-value,0.05 and concordant effect directions; Figure 2A–2B,
Figure 3C). The lower observed replication rate for the UW study
is partially attributable to the smaller sample size (60 vs 266), but
may also reflect platform-dependencies. 66.7% of significant cis-
eQTL associations replicated in at least one of the two replication
cohorts, while 47.6% replicated in both cohorts. Cis-eQTLs that
replicated in one replication study were significantly more likely to
replicate in the second replication study than expected by chance
(chi-squared p-value,2610
216) and twice-replicated eQTLs had
larger effect sizes than eQTLs that replicate in only one study
(Wilcoxon rank-sum test p-value,2610
216; Figure S5, examples
of non-replicated cis-eQTLs displayed in Figure S7).
Sample size, statistical power, and winner’s curse
Given differences in sample sizes among these studies, we
sought to define a baseline replication rate against which to
compare the observed levels of reproducibility. We therefore
conducted a re-sampling experiment in which, for each gene
expression trait, 100 sets of 60 sex and age (+/23 years) matched
samples were selected at random and used to define replication (i.e.
concordant effect direction and p,0.05). We found that simulated
replication rates increase dramatically near a BF of 5 (95.5%
replication at BF.5; Figure 3C) and are effectively 100% at higher
thresholds. These observations suggest that power differential
among the studies cannot alone explain the observed rates of
replication, as there are many genes with effect sizes in one study
that should be readily detected in both (let alone either) replication
panels. This is further supported by the observation that
concordance alone (i.e. no p-value threshold) yielded similar levels
of reproducibility, as did direct comparisons of allelic coefficients
(Spearman’s rho of 0.663 and 0.681 for UC–UW and UC-Merck
comparisons, respectively; Figure S6).
We next sought to evaluate whether ‘winner’s curse’ [33,34] was
deflating replication rates. Therefore, we extracted simulations in
which the estimated coefficients randomly decreased and found
that simulated replication remained .90% at BF.5 and near
100% at higher BF even when the effect size declined substantially
(e.g. 30% drop in regression coefficient; Figure S9). Effect sizes
would need to be over-estimated by 2-fold or greater across the
entire set of eQTLs with UC BF.5 to result in the observed rates
of replication. Furthermore, two lines of reasoning suggest
winner’s curse is not a major contributor to the observed rates
of non-replication. First, we note that bias resulting from winner’s
curse should be progressively less pronounced as the true effect size
increases, which in turn will correlate with significance estimates in
the discovery panel [34]. However, replication rate was essentially
flat even at extremely stringent thresholds (Figure 3C). Addition-
ally, the resampling experiments demonstrated that, in direct
contrast with a winner’s curse prediction, effect sizes would need to
be increasingly more severely over-estimated at higher thresholds
(3-fold or more) to result in the observed rates of replication
(Figure S8). Second, the definition of replication (concordance and
p-value,0.05) is relatively loose when applied to eQTLs with a
BF.5 (typical linear regression p-values,5610
28) and should
accommodate substantial drops in effect sizes for both replication
Table 1. Sample demographic summaries of all three studies.
Study
Category Subcategory University of Chicago
University of
Washington Merck
Final Sample # 206 60 266
Gender Male 131 32 137
Female 75 28 129
Age 25th percentile 21 28 40
50th percentile 46 45 52
75th percentile 59 55 62
Race European-American 183 55 266
Non-European 23 5 0
Genotyping platform Name Illumina 610 Quad Illumina 550K v3 Affymetrix 500K; Illumina 650Y
GEO accession GPL8887 GPL6981
Expression platform Name Agilent 4644K HumanRef-8 v.2 Agilent Custom
GEO accession GPL4133 GPL5060 GPL4371
Expression replicates Mean 2.25 2 1
Fraction expression probes overlapping
dbSNP130
0.274 0.191 NA
Data availability GEO series GSE26106 GSE26106 GSE9588
Publication this study this study PMID18462017
doi:10.1371/journal.pgen.1002078.t001
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supported by the observation that concordance alone yielded
similar rates of replication (Figure S6). We conclude that statistical
power and winner’s curse cannot explain the observed rates of
non-replication for eQTLs with BF.5.
On reproducibility failures due to hybridization artifacts
One possible explanation for non-replication is that SNPs
within sequences targeted by expression probes may change
hybridization efficiency in an allele-specific manner; if that SNP is
also correlated with a genotyped variant, false positive eQTLs may
result [35]. While 45.3% and 37.2% of Agilent and Illumina
probes overlap with a polymorphism found in dbSNP131 or the
one thousand genomes project (2010.08.04 release), the frequency
distribution of polymorphisms in and around probe sequences
differs markedly between the Agilent (UC) and Illumina (UW)
platforms (Figure S9); Illumina expression probes have clearly
been designed to avoid common polymorphisms.
Figure 2. eQTL characteristics. (A,B) Manhattan plots depicting best associated cis-eQTLs for all gene expression traits in the UC (A) and UW (B)
studies. Autosomes are ordered and alternately colored along the x-axis. BF of the SNP-gene pair is plotted on the y-axis. Probes overlapping
common polymorphisms are plotted as triangles, probes without known SNPs are plotted as open circles. For display purposes, genes with UC
BF.23 that replicate in the UW study are labeled with gene names. (C) Distribution of distances from each gene’s best associated SNP to its TSS.
Negative and positive values denote SNPs 59 and 39 of TSS, respectively. Data are plotted for all significant UC eQTLs (BF.5, black), eQTLs replicated
in the UW (red), Merck (blue), and eQTLs replicated in either UW or Merck (green).
doi:10.1371/journal.pgen.1002078.g002
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on reproducibility at extremely high thresholds (Figure 3C). For
example, the replication rate for cis-eQTLs with BF.5 is not
significantly affected by the presence of SNPs in probes (p-
value=0.189); however, replication rate for cis-eQTLs thre-
sholded at BF.10 is significantly affected by probe SNPs (p-
value=0.0354; 65.6% with, 74.9% without SNP) and replication
rate is significantly associated with an interaction between probe
SNPs and eQTL significance (logistic regression BF-SNP interac-
tion p-value=0.0224). These results suggest the proportion of
non-reproducible cis-eQTLs increases with eQTL significance
such that, for eQTLs with BF.10, ,27% of the non-replication
rate can be explained by the presence of hybridization artifacts
caused by known polymorphisms. To investigate the potential
confounding role of unannotated polymorphisms in eQTL
ascertainment, we re-sequenced 15 expression probes for genes
that had large discrepancies in correlation measurements between
the UW and UC studies that did not overlap a known SNP (9
probes with strong UW correlation but low UC correlation, 6 of
the converse; Table S2). We found that none of these 15 probes
harbored SNPs in the 60 UW liver samples or a panel of 35 CEU
HapMap samples. Collectively, our data suggest future array
designs/eQTL studies would benefit from more aggressive
avoidance of known SNPs, but current SNP annotations are
sufficiently comprehensive that unknown variants are of little
concern to eQTL analyses.
Surrogate variable analysis dramatically improves eQTL
reliability
We next quantified the role of several additional factors that
may generate spurious associations. Most strikingly, failure to
control for unknown or unmeasured confounding variables by
surrogate variable analysis (SVA) produced a large decrease in the
number of significant (BF.5) cis-eQTL signals (1,787 vs. 873;
Figure 4A; McNemar’s chi-squared test p-value,2610
216),
similar to a recent study of gene expression within twins [23].
Not only did SVA produce a larger number of significant cis-
eQTL associations, but these associations were also significantly
more likely to replicate (McNemar’s Chi-squared test p-val-
ue%2610
216; Figure 4B). While it has been shown that unknown
Figure 3. eQTL replication. (A) Number of gene expression traits (y-axis, log10 scaled) with best associated cis-eQTLs (black) and trans-eQTLs
(blue) as a function of BF (x-axis). Counts at each threshold are plotted separately for all probes (solid) and for probes without known polymorphisms
(dashed). (B) cis-eQTL associations were tested in two replication sample sets, UW and Merck. Replication sample linear regression t-test p-values
were binned (x-axis) and the number of genes per bin (y-axis) is displayed separately for the UW (red) and Merck (blue) replication sets. Data are
plotted for all eQTLs (thin lines) and for significant eQTLs (heavy lines). (C) cis-eQTL replication rate (y-axis) is depicted as a function of UC BF (x-axis)
for UW (red), Merck (blue), either replication study (green), and for the n=60 resampled data (purple). Replication rates are plotted separately for
probes overlapping known polymorphisms (solid lines) and for probes not overlapping an annotated polymorphism (dashed). (D) Cis-eQTL
replication rate (y-axis) plotted as a function of quantile binned SNP to TSS distance. Per bin mean (points) and standard errors (lines) are plotted
separately for associations with UC BF.0 (grey) with UC BF.5 (black), and with UC BF.10 (blue). (E) Trans-eQTL replication p-values were binned (x-
axis) and the number of genes per bin (y-axis) is displayed separately for the UW (red) and Merck (blue) replication sets. Data are plotted for all eQTLs
(thin lines) and for significant eQTLs (heavy lines). (F) trans-eQTL replication rate (y-axis) is depicted as a function of UC BF (x-axis) for UW (red), Merck
(blue), either replication study (green), and for the resampled data (purple).
doi:10.1371/journal.pgen.1002078.g003
Human Liver eQTL Replication and Fine-Mapping
PLoS Genetics | www.plosgenetics.org 6 May 2011 | Volume 7 | Issue 5 | e1002078or unquantified confounders can lead to unreliable genetic
predictions [19,36,2], our data show that such factors, if
unaccounted for, dramatically decrease the number of eQTL
signals and their reproducibility across multiple independent
collections of primary human tissues.
Other factors influencing reproducibility
Several additional aspects of the gene expression measurements
correlated with cis-eQTL replication rate. Cis-eQTL replication
rate was significantly associated with mean gene expression level
and, independently, inter-individual expression coefficient of
variation (Figure S10; multivariate logistic regression chi-squared
p-value=3.44610
23 and 1.41610
24, respectively); more highly
expressed and highly variable genes were more likely to replicate.
Further, we found that expression variance unexplained by age,
sex, race, and surrogate variables was negatively correlated with
expression level (Spearman’s rho=20.302, p-value,2610
216).
These data suggest greater measurement accuracy at higher
expression levels that leads to more robust eQTL identification.
We also found that the best associated SNP for each gene
expression trait was frequently immediately upstream or down-
stream from the transcription start site (TSS) (Figure 2C, [37]).
Replication rate of significant cis-eQTLs was associated with
absolute SNP to TSS distance (logistic regression chi-squared p-
value=5.35610
23). 74.5% of cis-eQTLs within 5 kb of the TSS
replicated, compared with only 60.6% located more than 100 kb
from the TSS. Thus while distal regulatory elements are clearly
important for human gene expression regulation, robustly
quantifiable, segregating expression polymorphism was more
likely to be found in SNPs very close to the TSS of genes.
Interestingly, significant cis-eQTLs were no more likely to
replicate when analyses were restricted to probes targeting the
same exon (chi-squared p-value=0.759), demonstrating that most
non-replicating eQTLs (in our study design) can not be accounted
for by differential splicing or isoform usage. Similarly, replication
was not improved when analyses were restricted to gene
expression measurements derived from more than one expression
probe (chi-squared p-value=0.919). Additionally, the minor allele
frequency of the associated SNP did not have a significant effect on
replication rate (logistic regression chi-squared p-value=0.600;
Figure S10), and eQTLs at imputed SNPs replicated at similar
rates to directly genotyped SNPs (logistic regression chi-squared p-
value=0.574; Figure S10). Uncertainty at imputed SNPs does not
appear to have a significant effect on cis-eQTL replication rate, as
the ratio of observed to expected genotype variance was not
associated with replication rate in any of the three sample sets
(logistic regression chi-squared p-values all .0.152; Figure S12).
Examination of the interplay of the factors influencing eQTL
replication revealed several interesting trends. As mentioned
above, replication probability was significantly associated with
SNP to TSS distance, but this association decreases with
increasing cis-eQTL significance (distance6BF interaction logistic
regression p-value=3.98610
25). Thus, location information can
help to differentiate real from false positive correlations of modest
effect, but is less important for very strong correlations. We
constructed stepwise multivariate logistic regression models,
restricted to associations with BF.5, and confirmed that BF
(logistic regression chi-squared p-value=7.32610
23), SNP to TSS
distance (p-value=2.33610
23), gene expression (p-val-
ue=0.0230), gene expression CV (p-value=1.33610
24), and
probe SNP6BF interaction (p-value=0.0207) all have significant
effects on the cis-eQTL replication rate. In contrast, SNP minor
allele frequency, SNP type (imputed or direct), and genotype
variance do not substantially influence replication rate (p-
values.0.5).
Trans-eQTLs
We also conducted genome-wide scans for associations between
gene expression traits and unlinked SNPs. Such trans-eQTLs may
represent regulatory interactions between transcription factors,
signaling molecules, or chromatin regulators and their target
genes. After adjusting for demographic variables as above, we
found 353 gene expression traits with significant (BF.5) trans-
linked genetic effects. The replication behavior of trans-eQTLs
was markedly different from cis-eQTLs (compare Figure 3B, 3C
with Figure 3E, 3F). First, the distribution of t-test p-values derived
from the UW replication set, for each best associated gene-SNP
pair identified in the UC set, was effectively uniform (Figure 3E).
Second, in contrast to cis-effects, which rapidly approach an
asymptotic replication rate at BF 5, trans-eQTLs almost
completely failed to replicate (6.14%; Figure 3F) at a BF threshold
of 5. At greater significance thresholds, trans effects did replicate
more frequently (e.g., at BF.=9.5, 50.0% replicate), however,
these rates never approached those observed for cis-eQTLs. It is
Figure 4. SVA improves eQTL reproducibility. (A) Surrogate variable regression produces more significant associations. Each point represents
the BF for each UC gene expression trait and its best associated SNP. Data are plotted for associations tested after surrogate variable regression (y-
axis) and unadjusted for surrogate variables (x-axis). Note that most points fall above the diagonal, indicating increased eQTL significance after
surrogate variable correction. (B) Cis-eQTL replication rate (y-axis; UC vs UW or Merck) as a function of UC BF threshold. SVA adjusted associations
depicted in black, unadjusted in grey.
doi:10.1371/journal.pgen.1002078.g004
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regulator effects, but as for cis-effects we identified more trans-
eQTLs with surrogate variable correction than without and these
associations were more likely to replicate (data not shown). While
it is perhaps surprising that even extremely significant trans effects
frequently fail to replicate, we note that this behavior is, to a
certain extent, to be expected [27].
Fine-mapping and functional characterization
As the eQTLs we identified are associations between effectively
anonymous SNPs and expression of a nearby gene, we were also
interested in fine-mapping the associations, ideally to a causal
variant (expression quantitative-trait-nucleotide or eQTN) or
haplotype. We therefore re-sequenced the promoter and 39UTR
sequences for 18 genes with strong cis-eQTLs within the 60 UW
livers (Table S3). Thirteen of these genes harbored a common
SNP or indel within the proximal promoter or 39UTR that
correlated strongly (p-value,1610
28) with the expression level of
that gene, while 17 of 18 harbored a variant with at least a modest
correlation (p-value,0.001). Of these 17 genes, the most strongly
correlated SNP was within the 39UTR for 11 genes and within the
promoter region for 6 genes. Moreover, 10 of the 17 best SNPs
were not within HapMap, indicating that a majority of the most
strongly associated promoter/39UTR variants were neither
genotyped directly nor imputed and therefore not detectable in
the original eQTL analysis.
We subsequently sought experimental support for the functional
nature of the most strongly associated SNPs. Therefore, for 14
genes, we cloned (and sequence-verified) common haplotypes
existing in the UW liver samples into a customized luciferase
reporter vector, and tested the function of each haplotype using
high-throughput, transient transfection reporter assays (Table S3;
9 of 14 underlying cis-eQTLs replicated in the UC or Merck
samples). For each haplotype, multiple independent vector (mode
of 3) preparations were made, and for each plasmid preparation 4
transfection replicates were performed (mode of 12 measurements
per haplotype). We analyzed the resulting data using a random-
effects model that accounted for both variation in transfection
replicates and variation in vector preparations. Our results
underscore the need to perform multiple independent DNA
preparations to reliably infer sequence-specific functional effects
with this system (Figure 5 and data not shown).
We identified three regions where the haplotype sequence had a
significant (p-value,0.001) effect on reporter activity (luminescence)
in the same allelic direction as the expression measurements,
including two promoters and one 39UTR region (Figure 5 and
Figure S12). No significant but discordant effects were observed.
Variants near PRMT6, which encodes a protein-arginine methyl-
transferase and has been associated with HIV infection progression
[38], scored highly in both the UW and UC eQTL analysis
(Figure 5A). Resequencing of the PRMT6 promoter yielded two
common haplotypes defined by two perfectly correlated SNPs located
406 and 150 bp upstream from the TSS. The minor haplotype (40%
frequency) correlated with a strong additive decrease in PRMT6 liver
expression (t-test p-value=6.4610
214 for UW), and relative to the
major haplotype, we found a concomitant decrease in luminescence
for reporter constructs harboring the minor haplotype (p-val-
ue=0.0002). A similar result was obtained for promoter haplotypes
of the LDHC (lactate dehydrogenase C) gene in which six common
variants defined 7 common haplotypes, five of which were
successfully cloned and tested. The strongest expression correlation
was observed for a SNP located 392 bp upstream of the TSS (15%
MAF),and the luciferasedata strongly supportthe functional effect of
this variant (p-value=8.7610
29; Figure 5B).
Finally, we identified a significant haplotype-specific effect
within the 39UTR for IPO8 (importin 8), a protein that interacts
with Argonaute proteins to direct miRNA mediated gene
expression regulation [39]. There were nine common 39UTR
haplotypes defined by 13 variants for IPO8. The two haplotype
groups defined by the most strongly expression-associated SNPs
(two perfectly correlated variants at positions 1147 and 1195
relative to the 39UTR start) have significantly different (p-
value=9.5610
24) functional effects. However, unlike LDHC,
there remained a substantial amount of variance within the
haplotypes defined by alleles at these two SNPs, suggesting other
variants may also have a functional role. Alternatively, the data
gathered from 39UTRs were generally noisier than that for
promoters (Figure 5 and data not shown), and may not be as
sensitive for identifying sequence-specific 39UTR effects. Due to
the increased noise, we repeated the analysis and performed new
clone preparations and transfections for a subset of the IPO8
haplotypes. The replicate data also show a significant (p-
value=0.007) difference, in the same direction, between haplo-
types defined by their 1147 (or 1195) allele (Figure S12).
Discussion
Genetic analyses of gene expression have great potential to
facilitate insights into the genetic basis of complex traits. However,
the utility of these data are limited by the extent to which the
discovered associations correspond to legitimate, reproducible
associations. Our estimates of 49% (UC vs. UW), 57% (UC vs.
Merck), and 67% (UC vs. either) cis-eQTL reproducibility are
substantially lower than two recent reports between two mouse
crosses (76%, [27]), two independent sets of lymphoblastoid cell
lines (83%, [25]), and two sets of primary human skin (.99%,
[26]). Several non-exclusive possibilities likely contribute to these
discrepancies. First, different discovery methodologies and repli-
cation criteria were employed in each study. Second, our studies
were performed on different expression platforms (Agilent and
Illumina), which reduces the influence of reproducible platform-
specific errors but may result in missing splice-variant-specific
eQTLs [40,41,10] as array manufacturers often target different
exons in a given gene. However, this is likely to have a limited
effect, as we found that the replication rate was not significantly
different for genes assessed by probes within the same exon (Figure
S10). Third, we compared three independent collections of
primary human tissues (see Methods), not transformed cell lines
or mouse tissues, and, despite the interpretive advantages
associated with the former, our replication rate estimate is possibly
downwardly biased by cell type heterogeneity. Finally, other
systematic differences between studies, including protocols for
sample collection and storage, clinical interventions taken by
patients prior to death and autopsy, causes of death, life histories,
etc., may contribute to non-reproducibility. This hypothesis is
supported by the observation that drug exposures and other
clinical covariates, for which data limitations prevent comprehen-
sive analysis, have substantial effects on gene expression; for
example, we found that drug metabolism genes were significantly
up-regulated in barbiturate-exposed vs non-exposed livers (data
not shown). The striking difference in reproducibility between the
results reported here and a recent report quantifying the overlap of
human skin eQTLs [26], suggests that the degree of functional
tissue heterogeneity may vary substantially across tissues.
An important caveat is that these estimates of reproducibility
are less meaningful for sequence-based studies of gene expression,
which offer advantages in dynamic range and measurement
accuracy [9,10]; sequencing is also largely immune to the SNP-in-
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(Figure 3C). However, the observation that age, sex, race, drug
exposures, clinical covariates, and other global factors have such
strong influences on expression (e.g., this study and [36,2]) coupled
with observations in other studies and different tissues that factors
like cause of death are relevant [42], suggests that much of the
non-reproducibility is in fact driven by systematic differences in
tissue source. Such differences will likely be important to all studies
of primary tissue samples, whether assayed by arrays or by
sequencing. The reproducibility of future results would benefit
from analysis of samples from multiple centers with as much
clinical information as possible. Furthermore, our results confirm
previous observations that the effects of unknown, unmeasured, or
unquantified covariates can confound genetic effects with
structured error sources [19,36,2], and that controlling for these
hidden confounders substantially boosts the rate of eQTL
discovery [23]. Importantly, we demonstrated that not only are
more eQTLs detected but that their reproducibility in indepen-
dent collections of primary human tissue was also significantly
higher.
Figure 5. Fine-mapping functional results. Functional fine-mapping results for three genes, presented in columns: PRMT6 (A, D, G), LDHC (B, E,
H), and IPO8 (C, F, I). (A–C) Cis-eQTL scan results are plotted across each gene region with chromosomal coordinates on the x-axis BF on the y-axis.
Genotyped SNPs are plotted in black, imputed SNPs in grey, promoter SNPs in green, and 39UTR SNPs in orange. The extent of each gene is plotted in
a red rectangle near the X-axis. Association data from the UC study plotted as triangles and from the UW study as circles. (D–F) Putative eQTNs
identified by promoter and 39UTR resequencing. Microarray expression measurements (residuals after regression against covariates, y-axis) for each
sample, plotted by genotype at the best-associated (ranked by p-value) SNP within the resequenced regions. Colors of the points correspond to the
luciferase data. (G–I) Luciferase reporter results. Normalized luciferase measurements (y-axis) are plotted for each tested clone corresponding to a
given haplotype (indicated by color). Blue and red coloring corresponds to the identity of each haplotype at the most strongly correlated individual
SNP (same as in the middle row), while varying shades of red and blue differentiate haplotypes that differ at other SNPs. Vectors for each haplotype
were prepared multiple independent times (data for each mini-prep are organized into a single column) and each mini-prep was transfected and
measured four times (each open circle indicates one of these 4 measurements). The mean luminescence for each mini-prep is shown as a solid circle.
doi:10.1371/journal.pgen.1002078.g005
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system [43], we found that of 14 tested genes, two genes
harbored functional eQTNs in the proximal promoter and one
gene harbored functional eQTNs in the 39UTR. The success
rate of 3 in 14 suggests that a substantial number of eQTLs, and
by extension any complex traits that they may influence, can be
functionally isolated using the scalable assay system that we
employed or potentially higher-throughput assays [44]. We note
that some truly functional variants will not be detectable in these
assays, either from being tested out of their genomic context or
having effect sizes below the limit of detection afforded by the
number of replicates used (e.g. [45]), and that the actual fraction
of eQTLs with promoter or 39UTR functional variation may be
substantially higher. Considering that replication was signifi-
cantly greater for eQTLs near the ends of genes relative to those
further away (Figure 3D), our functional analysis also strongly
supports the use of SNP to gene distance as an important
contributor to the prior probability that any given SNP is a cis-
eQTN [37]. While some eQTNs clearly reside outside these
regions (e.g., [46]), the heavy enrichment for reproducible and
experimentally tractable eQTNs, coupled with historical
evidence supporting disease relevance [47,48], suggests that
the relatively small ‘promoter’- or ‘39UTR’-ome target spaces
may be valuable additions to exome-based disease resequencing
efforts [49].
Given the ubiquitous importance of gene expression variance
to phenotype, the known heritability of gene expression
variance, and the great preponderance of non-coding functional
elements in the genome [50], complex disease studies can
benefit from eQTL analyses. Towards that end, we searched for
correlations between replicated eQTL SNPs identified here and
complex trait associated SNPs (R
2.80%; Table 2, Table S4) in
the NHGRI GWAS catalog (http://www.genome.gov/gwastu-
dies/). These included several previously characterized mech-
anistic links to complex traits, such as VKORC1 expression and
warfarin drug response [51] and SORT1 expression correlations
with lipid levels and heart disease [13], both of which were
originally identified using the UW liver panel described here.
Additionally, these data support a relationship, which had
previously been speculated but not shown to exist, between
NOD2 expression levels and leprosy risk [48], and novel
hypotheses such as a link between expression of the unchar-
acterized C2orf43 gene and prostate cancer risk [52].
In summation, our data facilitate insights into the factors and
experimental design criteria that affect eQTL reproducibility and
may improve future eQTL studies, replicate many published but
nonreplicated eQTLs (e.g. from [31]), support and extend eQTLs
identified in other tissues like brain (e.g. FAM119B [53]), identify
many novel reproducible liver eQTLs, show that promoters and
39UTRs are enriched for experimentally accessible functional
variation, and support or suggest numerous mechanistic links to
biomedically important phenotypes. We believe that this study and
others like it will be valuable to the robust discovery and fine-
mapping of the genetic basis for complex human diseases.
Methods
Ethics statement
Research conducted in this study was performed on deceased,
anonymous individuals and is therefore not considered to involve
‘human subjects.’ Samples were collected with approval of
institutional review boards (IRBs) and the University of Chicago
and University of Washington IRBs approved their use for the
purpose of this study.
Tissue procurement—UC
Livers wereprocessed through Dr. Mary Relling’slaboratory at St.
Jude Children’s Research Hospital, part of the Pharmacogenetics of
Anticancer Agents Research (PAAR) Group, and were provided by
the Liver Tissue Cell Distribution System funded by NIH Contract
#N01-DK-7-0004/HHSN267200700004C and by the Cooperative
Human Tissue Network. Samples were collected with approval of
institutional review boards (IRBs) and the University of Chicago IRB
has approved their use for the purpose of this study.
Analysis began with 240 normal (non-diseased) livers that were
collected from unrelated donors of self-reported European and
African descent. Most of the liver tissue samples come from donor
livers that were not used for whole organ transplants, the remainder
being from liver tissue which remains following a partial graft into a
smaller recipient, usually a pediatric patient. As such, each liver is
procured with the intent to transplant under the best possible
conditions to maintain cell viability. Standardized procedures have
been in place for handling, freezing and storage of the livers and
their subcellular fractionation and enzyme characterization.
Demographic information is summarized in Table 1.
Tissue procurement—UW
The University of Washington IRB approved the collection of
the liver tissues and their subsequent use for the purposes of this
study. Samples of human liver were obtained from organ donors
through the University of Washington Transplant Program and
the Northwest Organ Procurement Agency. Consent for research
was obtained in all cases. Standard procedures were employed for
the handling, freezing and storage of the livers.
Gene expression analysis—UC
Gene expression microarray experiments were conducted with
biological replication in all samples. Sample processing order was
randomized. For each sample, total RNA was extracted at least
twice independently, from tissue homogenized in TRIzol reagent,
followed by Qiagen RNAeasy cleanup (Qiagen). RNA quality was
assessed by Bioanalyzer (minimum RIN=7). cRNA was produced
using the Agilent Low-Input Linear amplification and labeling kit.
Array hybridizations (Agilent-014850 4644 k arrays, GPL4133)
were performed at The University of Chicago, Argonne National
Labs high throughput genome analysis core facility, according the
manufacturers instructions. The Agilent FE software was used to
extract feature intensities and to flag saturated, non-uniform, and
outlier features. Probe intensity was adjusted by subtracting
background intensity using the minimum method [54,55] and
quantile normalized between arrays [56]. Dixon’s outlier test was
used to remove 13 arrays (out of a total of 517) based on total
number of flagged probes, intra-array variance, inter-array
variance, biological replicate variance, and spike-in linearity [57].
Probes were grouped into probe sets by aligning first to RefSeq
gene annotations and then aligning unmapped probes to the human
reference genome (build 36). All probes with non-unique best
alignments were excluded from further analysis. Multiprobe
probesets were hierarchically clustered using one minus the pearson
correlation coefficients as a distance matrix. Clusters were divided
into groups by cutting clusters at a dendrogram height of 0.5
(roughly producing clusters with internal correlation coefficients
.0.5). All downstream analyses were performed independently on
each resulting cluster and all single probe probesets.
Gene expression analysis—UW
Total RNA was extracted from 60 human liver tissue samples
from the University of Washington School of Pharmacy Human
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expression analysis was performed using 750 ng of total RNA on
the Illumina HumanRef-8 v.2 platform (GPL5060). All liver
samples were analyzed with technical replicates that were
randomized between processed batches of 24 arrays performed
on different days. Raw signal intensity measurements from each
sample were processed using the Illumina BeadStudio software v.
2.3.41 using the ‘average’ normalization function. Replicate data
from each liver was averaged prior to statistical analysis. All
samples and replicates passed quality-control measures.
Gene expression analysis—Merck
Processed gene expression data from the published Merck liver
eQTL study [31] were downloaded from GEO (GSE9588,
GPL4371). Based on available sample metadata, 266 samples
had (a) unambiguous sample ID, age and sex assignments (b)
expression data, (c) genotype data, and (d) did not overlap with the
UC study. Probes were grouped into RefSeq gene annotation
probe sets based on the array manifest. Probesets were further
clustered and split following the methodology used for the UC
array set.
Genotyping—UC
From the same liver samples received from the Liver Tissue
Resource, DNA was obtained from 240 samples for genotyping.
Genotyping was performed on the Illumina human 610 quad
beadchip platform (GPL8887) at the Northwestern University
Center for Genetic Medicine Genomics Core Facility according to
the manufacturer’s instructions. One sample was removed because
it had a no call rate .10%. The initial marker set comprised
620,901 markers. 8,300 markers were removed because they
showed significant deviation from Hardy-Weinberg equilibrium
Table 2. Selected overlap between liver eQTLs and GWAS SNPs.
Traits GWAS SNPs eQTL SNP Chr eQTL Gene UC BF Replication?
LDL cholesterol, Blood lipid traits, Coronary heart
disease
rs12740374; rs660240; rs629301;
rs646776; rs599839
rs12740374 1 SORT1 30.553 UW, Me
Body mass index rs10838738 rs3817335 11 MTCH2 28.316 Me
Systemic lupus erythematosus rs9271100 rs9271100 6 HLA-DRB5 23.186 UW
Height rs10935120 rs11919350 3 ANAPC13 20.007 UW, Me
Activated partial thromboplastin time rs2731672 rs2731672 5 F12 18.961 UW, Me
LDL cholesterol, Blood lipid traits, Coronary heart
disease
rs12740374; rs660240; rs629301;
rs646776; rs599839
rs12740374 1 CELSR2 18.657 UW, Me
Meningococcal disease rs426736 rs1065489 1 CFHR4 17.785 Me
Warfarin maintenance dose rs10871454; rs9923231 rs2303222 16 VKORC1 15.939 UW, Me
Cholesterol, total rs10903129 rs1053438 1 TMEM50A 14.231 UW
Other erythrocyte phenotypes rs2075671 rs11520986 7 GIGYF1 13.964 UW
Prostate cancer rs13385191 rs13385191 2 C2orf43 13.87 UW, Me
Multiple sclerosis rs703842 rs8181644 12 TSFM 12.711 UW, Me
QT interval rs37062; rs7188697 rs4784051 16 SETD6 12.174 Me
Height rs9487094 rs9487100 6 SMPD2 11.478 Me
Leprosy rs9302752 rs9302752 16 NOD2 10.603 UW, Me
Chronic kidney disease rs1933182 rs4970767 1 ATXN7L2 10.004 UW, Me
Hematological parameters rs210135 rs210142 6 BAK1 9.517 UW, Me
Primary tooth development (number of teeth) rs6504340 rs7207109 17 HOXB2 9.07 UW, Me
Multiple sclerosis; Height rs1790100; rs11830103 rs1060105 12 CDK2AP1 8.968 UW, Me
Vertical cup-disc ratio; Esophageal cancer and
gastric cancer
rs1547014; rs738722 rs1547014 22 CHEK2 8.827 Me
Height rs10935120 rs9968172 3 CEP63 7.354 UW, Me
Type 1 diabetes rs3825932 rs11638844 15 CTSH 7.25 UW, Me
Pulmonary function rs10516526 rs10516525 4 INTS12 6.887 UW
Height rs6060369; rs6060373; rs6088813 rs6141548 20 UQCC 6.824 UW, Me
Height rs4886707 rs10220738 15 MAN2C1 6.441 Me
Cholesterol, total rs10903129 rs12027135 1 RHCE 6.334 Me
Plasma coagulation factors rs867186 rs867186 20 PROCR 6.077 Me
Bipolar disorder rs11622475 rs11625697 14 TDRD9 5.742 UW, Me
Bone mineral density (spine) rs2016266; rs10876432 rs6580942 12 ESPL1 5.689 Me
Mean corpuscular hemoglobin rs11085824 rs11085825 19 GCDH 5.569 UW, Me
Conduct disorder (interaction) rs2282301 rs12037177 1 RIT1 5.521 UW, Me
Factor VII rs561241 rs7981123 13 F7 5.477 UW, Me
doi:10.1371/journal.pgen.1002078.t002
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from the analysis because they had a no call rate in more than
.10% of the samples. Hence, our final marker set is comprised of
583,073 SNPs. Identity by descent analysis, performed in Plink,
revealed 14 pairs of duplicated samples. Erroneous, redundant
sample collection was later confirmed by the tissue bank.
Genotype and expression data for these samples were merged
for all downstream analyses. The final sample set therefore
consisted of 225 unique samples.
Genotyping—UW
Genotyping was performed on each liver sample using the
Illumina HumanHap550 (GPL6981) Beadchip platform. Geno-
typing calls were made using GenomeStudio. After raw genotyp-
ing data were loaded into the software, pre-defined cluster
definitions were applied and genotype calls were determined.
Clusters were checked for separation, deviation from HWE, and
lack of variation (i.e., monomorphic). Poorly assigned clusters were
modified manually and sites were re-called with corrected cluster
definitions. All samples had call rates greater than 98%.
Genotyping—Merck
Genotype data were generated as described [31].
Sex confirmation
The sex of each sample was imputed by K-means clustering of
Y-linked gene expression levels and X- and Y-linked genotypes. 3
UC samples, 0 UW samples, and 0 Merck samples had
mismatched imputed and annotated sexes, and were therefore
excluded from all analyses.
Genotype imputation
For all three studies, care was taken to translate all genotypes to
reference genome (b36) forward strand alleles, as subtle errors in
genotype strand inference will downwardly bias replication rate
estimates. Additional genotypes were imputed with Bimbam (v
0.99) [58], using HAPMAP release 27, build 36 unphased
genotypes as reference panels. European American genotypes
were imputed with a CEPH reference panel, while African
American genotypes were imputed with a combined CEPH and
YRI panel. Imputation was run with default Bimbam parameters,
and mean imputed genotypes were recorded and used for all
downstream analyses.
Quantification of ancestry—UC
We performed a principal component analysis (PCA) based
quantification of race using the African and European populations
from the Human Genome Diversity panel as reference popula-
tions. The SNP set was trimmed using linkage disequilibrium
(LD)-based SNP pruning, removing all SNPs for with high
pairwise LD (R
2.0.8), as in [59]. PCA was performed using
smartpca, as implemented in EIGENSOFT [60]. Four samples
were flagged as outliers and removed from all further analyses. As
expected, the first principal component separated African from
non-African individuals. We therefore used this loading vector as
an estimated quantification of African ancestry for further
analyses.
Quantification of ancestry—UW
PCA was performed using the multi-dimensional scaling
procedure implemented in PLINK v1.06 (http://pngu.mgh.
harvard.edu/purcell/plink/) [61]. The vast majority of samples
resided in a single cluster including all the individuals of self-
reported European ancestry, with several moderately outlying
samples corresponding to self-reported Hispanic and African
ancestry. No samples were excluded from further analyses; the
vectors determined for the first two principal components were
used as ancestry control for all statistical analyses.
Quantification of ancestry—Merck
All 266 samples included from the published Merck study were
self-reported Caucasians. The SNP set was trimmed using linkage
disequilibrium(LD)-basedSNPpruning,removingallSNPsforwith
high pairwise LD (R
2.0.8), as in [59]. PCA was performed using
the multi-dimensoinal scaling procedure implemented in PLINK
v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/) [61]. No
outliers were detected; the vectors determined for the first four
principal components were used as ancestry control for all statistical
analyses.
Covariate modeling—UC
For each probeset, surrogate variable analysis (SVA) [20] was
performed on the matrix of expression measurements, after
controlling for the effects of hybridization protocol, age, sex, and
a principal component analysis based quantification of genetic
ancestry. For each probeset, we then constructed a linear mixed
effects model y , m + P + A + C + R + I + W + SVi..n + e, where y is
the log2 transformed probe intensity, m is the expected probe
intensity, P is a factor controlling for the effect of subtle variations
in hybridization protocol (e.g., the identity of the technician who
performed the experiment), A is the effect of individual age, and C
is the effect of individual sex, and R is the effect of genetic ancestry.
I is the random effect of each individual, W is the random effect of
the oligonucleotide probe, SVi..n represents the effects of a matrix
of 55 surrogate variables, and e is the residual error. The model
was fitted to each gene by residual maximum likelihood using the
lmer function in the R package lme4 (v 0.999375-32) [62,63].
Fixed effect p-values were estimated using the pvals.fnc function in
the languageR package (v 1.0) [64]. The significance of covariate
effects was assessed by estimating false discovery rates, using
Storey’s q-value method [65]. To further control for the effects of
outliers and population stratification, prior to eQTL mapping, the
distribution of estimated individual effects, for each gene
expression trait, was normal quantile transformed, within
populations.
Covariate modeling—UW
SVA [20] was performed on the matrix of expression
measurements, after controlling for the effects of age, sex, and a
multidimensional scaling based quantification of genetic ancestry.
For each probe, we constructed a linear model y , m + A + C + R
+ SVi..n + e, where y is the log2 transformed probe intensity, m is the
expected probe intensity, A is the effect of individual age, and C is
the effect of individual sex, and R is the effect of genetic ancestry,
SVi..n represents the effects of a matrix of surrogate variables, and e
is the residual error. Models were implemented with the lm
function in R. The residuals from this regression were used as the
phenotype values for all subsequent analyses.
Covariate modeling—Merck
SVA [20] was performed on the matrix of expression
measurements, after controlling for the effects of age, sex, and a
principal component analysis based quantification of genetic
ancestry; 54 significant surrogate variables were identified. For
each probeset, we then constructed a linear model y , m + A + C +
R + W + SVi..n + e, where y is the log2 transformed probe intensity,
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and C is the effect of individual sex, and R is the effect of genetic
ancestry, W is the effect of the oligonucleotide probe, SVi..n
represents the effects of a matrix of surrogate variables, and e is the
residual expression. Models were implemented with the lm
function in R. The residuals from this regression were used as
the phenotype values for all subsequent analyses.
eQTL mapping
For each gene expression trait, residual expression variance was
treated as a quantitative trait and tested for association with all
markers genome-wide. Association testing was performed by
Bayesian regression, as implemented in Bimbam (v 0.99), using
mean imputed genotypes and default priors [28,29]. Genotypes
with minor allele frequencies less than 1% were excluded.
Probe resequencing
For 15 probes that showed discrepant eQTL scores between the
UC and UW analyses (i.e. BF.4 in one study and BF,4 in the
other), we designed primers to capture the relevant expression
array probe and amplified and Sanger-sequenced the resulting
PCR products in each of the 60 UW liver samples and 35 CEU
HapMap samples. SNPs were identified as previously described
(http://pga.gs.washington.edu/) including both automated pre-
diction and manual curation.
Fine-mapping
We resequenced the promoter and 39UTR regions within the
60 UW liver samples and 35 CEU HapMap samples for 18 genes
that showed strong expression-SNP correlations within the UW
data (selected before replication information was available). We
used PCR amplification and Sanger-sequencing, identifying SNPs
using both automated prediction and manual curation as
previously described (http://pga.gs.washington.edu/). 39UTRs
were defined using the appropriate gene models, while promoters
were defined as the 1 kb segment upstream of the annotated
transcriptional start site. We subsequently defined haplotypes
within each promoter and 39UTR as previously described using
Phase [58], and designated as common all haplotypes present in at
least two samples.
Common haplotypes for each of 14 promoter and UTR regions
were PCR-amplified and cloned into luciferase-reporter vectors.
Promoter haplotypes were cloned immediately upstream of the
luciferase reporter gene, while 39UTRs were placed at the 39 end
of a luciferase gene whose expression is driven by the RPL10
promoter that has strong constitutive activity (vector maps
available from SwitchGear Genomics, http://switchgeargenomics.
com/resources/vector-maps/). We then transfected each of these
constructs into HEPG2 cells, a liver-derived cell line, and
measured luminescence. Each haplotype was tested using multiple
(mode=3) vector preparations and 4 technical transfection
replicates measurements were obtained for each vector prepara-
tion (12 or more measurements for most haplotypes).
Transient transfection reporter assays were all performed in 96-
well format. Transfection complexes were formed by incubating
100 ng of each individual promoter construct with 0.3 mLo f
Fugene 6 transfection reagent and Opti-MEM media in a total
volume of 5 mL and incubated for 30 min. Transfection complexes
(5 uL) were added to 10,000 HepG2 cells in 96-well format that
had been seeded 24 h prior to transfection in a white tissue-culture
treated plate.
After seeding and transfection, cells were incubated for 48 h
before freezing at 280 degrees overnight. To read luminescent
activity, plates were thawed for 45 min at room temperature.
Then 100 mL of Steady-Glo reagent (Promega #E2520) was
added and incubated for 30 min at room temperature. Then
luminescence was read for 2 s per well on a 384-well compatible
plate luminometer (Molecular Devices LMax384).
To identify significant in vitro effects of haplotype on luminescence,
we employed a mixed-effects model using the lmer package [63]
within R [62], grouping the replicate luminescence measurements by
mini-prep identifier (treating the mini-prep as a random effect). The
haplotype identifier has a significant effect on luminescence at p-
value,0.001 for each of the three reported associations between
haplotype sequence and luminescence measurement. No additional
correlations were significant at this threshold.
Supporting Information
Figure S1 UW best SNP analyses. (A) Number of gene traits (y-
axis) with best associated cis-eQTLs in bins of increasing
association significance (x-axis). (B) Distribution of distances from
each gene’s best associated SNP to its transcription start site (TSS).
Negative and positive values denote SNPs 59 and 39 of TSS,
respectively. (C) Distribution of linear regression SNP-expression
association t-test p-values from the UC (red) and Merck (blue)
sample sets for all genes and their most associated cis-SNP in the
UW study. Gene counts (y-axis) are plotted per p-value bin (x-
axis). Data are plotted for all eQTLs (thin lines) and for significant
eQTLs (heavy lines). (D) Between study cis-eQTL effect
replication rate (y-axis) plotted as a function of UW cis-eQTL
significance threshold (x-axis). UW vs. UC (red), UW vs. Merck
(blue), and UW vs. either (green) replication rates are plotted
separately . (E) cis-eQTL replication rate (y-axis) as a function of
distance from the best associated SNP to the gene TSS (x-axis).
Data are plotted separately for eQTLs with BFs.0 (grey) and
BFs.5 (black). eQTLs were binned in 2.5% quantiles; mean
(circle) and standard error of the mean (bar) are plotted for each
bin. (F) cis-eQTL replication rate (y-axis) as a function of the linear
model minor allele count fixed effect coefficient (x-axis). Data are
plotted as in E. (G) Between study cis-eQTL effect correlation
coefficient (y-axis) plotted as a function of UW cis-eQTL
significance threshold (x-axis). UW vs. UC (red), UW vs. Merck
(blue).
(EPS)
Figure S2 Mean square (MS) distributions for each factor across
all three studies. For the UC (red), Merck (blue), and UW (green)
datasets, the average MS value for all genes is plotted (open circles,
y-axis) for each indicated covariate (x-axis) in a model that includes
all covariates, Error bars are drawn from one standard error
(s.e.m) above to one standard error below the mean.
(EPS)
Figure S3 Examples of age- and sex-associated genes. Surrogate
variable adjusted per-probe, per-sample residual expression data
are depicted for six genes. Three genes (top row: CD40, FGF2,
HDAC1) are significantly associated with sex and three genes
(bottom row: PPARA, HRAS, TMEM22) are significantly associat-
ed with age. Each point represents the expression level of a single
individual, as measured by a single gene expression probe. Data
from males are plotted in black, females in red. Linear regression
coefficient t-test p-values are provided.
(EPS)
Figure S4 Correlation of covariate effects. (A,B) Correlation
coefficient (y-axis) for sex (A) and age (B) regression coefficients as
a function of discovery sample association p-value (x-axis), plotted
separately for UC-UW (red) and UC-Merck (blue) comparisons.
(EPS)
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eQTLs. (A) Effect size and (B) Bayes Factor distributions for singly
and doubly replicated eQTLs.
(EPS)
Figure S6 Alternate replication metrics for eQTLs. (A)
Correlation coefficient between linear model minor allele count
fixed effect regression coefficients (y-axis) as a function of
discovery sample cis-eQTL significance (x-axis). Correlations
were calculated separately between UC and UW (red) and
between UC and Merck (blue). Imputed cis-eQTL SNPs are
plotted in dashed lines and directly genotyped SNPs are plotted
in blue. (B) Concordance rates between linear model minor
allele count fixed effect regression coefficients (y-axis) as a
function of discovery sample cis-eQTL significance (x-axis).
Concordance was calculated separately between UC and UW
(red), between UC and Merck (blue), and between UC and
either Merck or UW (green). Note that we adjusted the raw
c o n c o r d a n c er a t e st oa c c o u n tf o rt h ef a c tt h a t5 0 %o fa l lf a l s e
positives would replicate using this definition for a single
replication panel and 75% would replicate in the ‘either’
category (50% of false positives using one replication panel,
50% of the remainder using the second). So, for example, a
concordance rate of 80% between UC and a given replication
panel results in a replication estimate of ,60%, since we assume
that the 20% of eQTLs that are discordant represent only half
of all false positives. Similarly, a concordance rate of 90% using
an ‘either’ standard also results in a replication estimate of 60%,
since we assume that the 10% of effects that are discordant
represent only a quarter of all false positives.
(EPS)
Figure S7 Examples of replicating and non-replicating cis-
eQTLs. Residual gene expression (left y-axis) or raw gene
expression measurements (right y-axis) plotted as a function of
minor allele count (x-axis). Left column depicts UC data, center
column Merck data, and right column UW data. Three UC cis-
eQTLs that (A) replicate in UW but not Merck, (B) replicate in
Merck but not UW, (C) that replicate in neither study, and (d) that
replicate in both.
(TIF)
Figure S8 Simulation based estimates the relationship between
effect size bias (winner’s curse) and replication rate. (A) Age (+23
years), sex, and race matched sets of 60 individuals were sampled
from the UC data set and used to calculate a baseline replication
rate. Replication rate (y-axis) is plotted as function of the ratio of
full-dataset to resampled minor allele fixed effect coefficients (x-
axis). Data are plotted separately for cis-eQTL sets that were
thresholded at varying BF values. (B) The distribution of observed
to resampled minor allele fixed effect coefficients were binned (x-
axis) and the density of simulations per bin is plotted on the y-axis.
As in (A), data are plotted separately for cis-eQTL sets that were
thresholded at varying BF values.
(EPS)
Figure S9 Distribution of SNPs within and flanking Agilent,
Illumina expression probes. Distribution of SNP counts (y-axis) at
varying distances from the start coordinate of each expression
probe (x-axis), depicted for both the Agilent (A) and Illumina (B)
expression arrays. Black bar delineates the extent of the probe
sequence. Note that Agilent and Illumina probes are 60 and 50
nucleotides long, respectively.
(EPS)
Figure S10 Expanded analysis of determinants of replication
probability. (A) Between study cis-eQTL effect replication rate
(y-axis) plotted as a function of UC cis-eQTL significance
threshold (x-axis). Data are plotted separately for probes sets for
which both the UC and UW expression array probes target the
same exon (grey) and those for which they target different exons
(black). Differences are not significant. (B–H) Replication rate
between the UC and UW or Merck studies (y-axis) for all cis-
eQTLs with BF.0 (grey), BF.5 (black), and BF.10 (blue)
whose probes overlap a known polymorphism. (B) Cis-eQTLs
are binned by the distance of the SNP from the 59 end of the
microarray expression probe (x-axis). Mean replication rate
(points) and standard error of the mean (lines) are plotted per
bin. (C) Cis-eQTLs are binned by the number of known
polymorphisms overlapping the expression probe (x-axis).(D) Cis-
eQTLs are binned by mean log2 gene expression level (x-axis).
(E) Cis-eQTLs are binned by the coefficient of variation of log2
gene expression levels (x-axis). (F) Cis-eQTLs are binned by the
linear model minor allele count fixed effect regression coefficient
(x-axis), as estimated from the discovery samples. (G) Cis-eQTLs
are binned by the mean residual linear model variance (x-axis),
after adjusting for demographic and technical covariates. (H)
Cis-eQTLs are binned by minor allele frequency (x-axis). (I)
Between study cis-eQTL effect replication rate (y-axis) plotted as
a function of UC cis-eQTL significance threshold (x-axis). UC
vs. UW (red), UC vs. Merck (blue), and UC vs. either (green)
replication rates are plotted separately . Replication rates are
plotted separately for SNPs that were directly genotyped (dashed
lines) and those that were imputed (solid lines). (J) UC-UW cis-
eQTL effect replication rate (y-axis) plotted as a function of UC
cis-eQTL significance threshold (x-axis). Replication rates are
plotted separately for SNP pairs for which both SNPs were
directly genotyped (red), both SNPs were imputed (green), and
for which one SNP was imputed and one was directly genotyped
(blue). (K) UC-Merck cis-eQTL effect replication rate (y-axis)
plotted as a function of UC cis-eQTL significance threshold (x-
axis). Replication rates are plotted separately for SNP pairs for
which both SNPs were directly genotyped (red), both SNPs were
imputed (green), and for which one SNP was imputed and one
was directly genotyped (blue). (L) Replication rate between the
UC and UW or Merck studies (y-axis) for all cis-eQTLs with
BF.5. Cis-eQTLs are binned by minor allele frequency (x-axis)
and plotted separately for imputed (orange) and directly
genotyped (black) SNPs.
(EPS)
Figure S11 Imputation quality and replication. (A–C) Histo-
grams depicting the number of imputed (red) and directly
genotyped (blue) SNPs (y-axis) binned by the ratio of observed
over expected genotype variance (x-axis). Expected genotyped
variance calculated based on observed HAPMAP genotype
frequencies. Data are plotted separately for UC (A), UW (B),
and Merck (C) genotypes. (D) Replication rate between the UC
and UW or Merck studies (y-axis) for cis-eQTLs with BF.0 (grey),
BF.5 (black). Cis-eQTLs are binned by the UC ratio of observed
to expected (based on CEU minor allele frequencies) genotype
variance (x-axis). (E) Replication rate between the UC and UW (y-
axis) for cis-eQTLs with BF.0 (grey), BF.5 (black). Cis-eQTLs
are binned by the UW ratio of observed to expected genotype
variance (x-axis). (F) Replication rate between the UC and Merck
(y-axis) for cis-eQTLs with BF.0 (grey), BF.5 (black). Cis-eQTLs
are binned by the Merck ratio of observed to expected genotype
variance (x-axis).
(EPS)
Figure S12 Replication of IPO8 39 UTR expression effect.
Reporter construct clones from each 39 UTR haplotype were
Human Liver eQTL Replication and Fine-Mapping
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Figure 5. Data depicted as in Figure 5, bottom panel.
(TIF)
Table S1 All gene eQTLs. Each gene and all three studies,
covariate effects, eQTL effects, linear model coefficients, Bayes
Factors, SVA effects, and UC best-associated SNP annotation.
(BZ2)
Table S2 Expression probe re-sequencing.
(XLSX)
Table S3 Luciferase results table.
(XLSX)
Table S4 Extended overlap of GWAS associations and liver
eQTLs, including all UC best-associated gene-SNP pairs regard-
less of BF or replication status.
(XLSX)
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